Conflict of Interest: Can We Minimize Its Influence in the Biomedical Literature?

References

1. ↵
   Genuis SJ. The proliferation of clinical practice guidelines: professional development or medicine-by-numbers? J Am Board Fam Pract 2005; 18: 419–25.

   OpenUrlAbstract/FREE Full Text
2. ↵
   Abramson J, Starfield B. The effect of conflict of interest on biomedical research and clinical practice guidelines: can we trust the evidence in evidence-based medicine? J Am Board Fam Pract 2005; 18: 414–8.

   OpenUrlFREE Full Text
3. ↵
   Thompson D. Understanding financial conflicts of interest. N Engl J Med 1993; 329: 573–6.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   [Editorial]. Publishing commentary by authors with potential conflicts of interest: When, why, and how. Ann Intern Med 2004; 141: 73–4.

   OpenUrlPubMedWeb of Science
5. ↵
   Dana J, Loewenstein G. A social science perspective on gifts to physicians from industry. JAMA 2003; 29: 252–5.

   OpenUrl
6. ↵
   Bowman MA. The impact of drug company funding on the content of continuing medical education. Möbius 1986; 6: 66–9.

   OpenUrl
7. ↵
   Bowman MA, Pearle DL. Changes in drug prescribing patterns related to commercial company funding of continuing medical education. J Cont Educ Health Prof 1988; 8: 13–20.
8. ↵
   Wazana A. Physicians and the pharmaceutical industry. Is a gift ever just a gift? JAMA 2000; 283: 373–80.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   Chervenak FA, McCullough LB. An ethical framework for identifying, preventing, and managing conflicts confronting leaders of academic health centers. Acad Med 2004; 79: 1056–61.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    Perlis CS, Harwood M, Perlis RH. Extent and impact of industry sponsorship conflicts of interest in dermatology research. J Am Acad Dermatol 2005; 52: 967–71.

    OpenUrlCrossRefPubMedWeb of Science
11. Kjaergard LL, Als-Nielsen B. Association between competing interests and authors’ conclusions: Epidemiological study of randomized clinical trials published in the. BMJ 2002; 325: 249.

    OpenUrlAbstract/FREE Full Text
12. Schulman KA, Seils DM, Timbie JW, Sugarman J, Dame LA, Weinfurt KP, Mark DB, Califf RM. A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. N Engl J Med 2002; 347: 1335–41.

    OpenUrlCrossRefPubMedWeb of Science
13. Choudhry NK, Stelfox HT, Detsky AS. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 2002; 287: 612–7.

    OpenUrlCrossRefPubMedWeb of Science
14. ↵
    Friedman LS, Richter ED. Relationship between conflicts of interest and research results. J Gen Intern Med 2004; 19: 51–6.

    OpenUrlCrossRefPubMed
15. ↵
    Charlton BG. Conflicts of interest in medical science: peer usage, peer review and ‘Col consultancy’. Med Hypotheses 2004; 63: 181–6.

    OpenUrlPubMed
16. Drazen JM, Curfman GD. Financial associations of authors. N Engl J Med 2002; 346: 1901–2.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    International Committee of Medical Journal Editors. “Uniform Requirements for Manuscripts Submitted to Biomedical Journals.” Available at: www.icmje.org. Accessed July 5, 2005.
18. ↵
    DeAngelis CD, Fontanarosa PB, Flanagin A. Reporting financial conflicts of interest and relationships between investigators and research sponsors. JAMA 2001; 286: 89–91.

    OpenUrlCrossRefPubMedWeb of Science
19. ↵
    Davidoff F, DeAngelis C, Drazen JM, Hoey J, Hojharrd L, Horton R. Sponsorship, authorship, and accountability. Lancet 2001; 358: 854–6.

    OpenUrlCrossRefPubMedWeb of Science